Edition:
United States

Joincare Pharmaceutical Group Industry Co Ltd (600380.SS)

600380.SS on Shanghai Stock Exchange

11.15CNY
15 Dec 2017
Change (% chg)

¥-0.52 (-4.46%)
Prev Close
¥11.67
Open
¥11.60
Day's High
¥11.60
Day's Low
¥11.10
Volume
33,760,190
Avg. Vol
34,855,678
52-wk High
¥13.99
52-wk Low
¥8.10

Latest Key Developments (Source: Significant Developments)

Livzon Pharmaceutical Group unit receives approval for drug clinical trial
Friday, 3 Nov 2017 04:13am EDT 

Nov 3 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says its unit received drug clinical trial approval for Recombinant Humanized anti-PD-1 Monoclonal Antibody for Injection .  Full Article

Joincare Pharmaceutical Group Industry unit receives approval for drug clinical trial
Friday, 3 Nov 2017 01:48am EDT 

Nov 3(Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says co's Zhuhai-based biotechnology unit received approval for drug clinical trial, regarding recombinant humanized anti-PD-1 monoclonal antibody for injection, from China Food and Drug Administration.  Full Article

Joincare Pharmaceutical Group Industry sees FY 2017 net profit up 337.2 pct to 370.3 pct
Friday, 27 Oct 2017 01:27am EDT 

Oct 27 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says it sees net profit for FY 2017 to increase 337.2 percent to 370.3 percent, or to be 1.97 billion yuan to 2.12 billion yuan.Says the net profit of FY 2016 was 451.4 million yuan.Comments that sale of unit as main reason for the forecast .  Full Article

Joincare Pharmaceutical Group's 9-month net profit up 441.9 pct y/y
Thursday, 26 Oct 2017 07:17am EDT 

Oct 26 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says 9-month net profit up 441.9 percent y/y.  Full Article

Joincare Pharmaceutical Group Industry units get drug clinical trial approval for Tobramycin Inhalation Solution
Wednesday, 25 Oct 2017 02:47am EDT 

Oct 25 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS> ::Says its units and partners get drug clinical trial approval for Tobramycin Inhalation Solution.  Full Article

Joincare Pharmaceutical expects 9-month net profit to rise to 2.0-2.1 bln yuan
Friday, 13 Oct 2017 07:01am EDT 

Oct 13 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says it expects 9-month net profit to rise to 2.0-2.1 billion yuan from 373.8 million yuan ($56.76 million) year ago.  Full Article

Livzon Pharmaceutical Group unit receives approval for drug clinical trial
Monday, 11 Sep 2017 03:55am EDT 

Sept 11 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:* Says its unit received drug clinical trial approval for antineoplastic, Paclitaxel polymeric micelles for injection .  Full Article

Joincare Pharmaceutical Group Industry says 2016 A share dividend payment date on Aug. 4
Monday, 31 Jul 2017 05:24am EDT 

July 31(Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says it will pay a cash dividend of 0.16 yuan per share (before tax) for 2016 to shareholders of A shares recorded on Aug. 3.Says the company's shares will be traded ex-right and ex-dividend on Aug. 4 and the dividend will be paid on Aug. 4 .  Full Article

Joincare Pharmaceutical Group Industry issues 400 mln yuan worth of super short-term debentures
Monday, 26 Jun 2017 12:14am EDT 

June 26 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS> ::* Says it issues 2017 first tranche super short-term debentures worth of 400 million yuan, with interest rate of 4.88 percent .  Full Article

Joincare Pharmaceutical Group plans share issue, share trade to resume
Thursday, 11 May 2017 07:26am EDT 

May 11 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says its shares to resume trade on May 12.Says it plans to issue A-shares to raise up to 2.0 billion yuan ($289.79 million).  Full Article